Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03858972
Brief Title: Tesetaxel Plus Reduced Dose of Capecitabine in Patients With HER2 Negative, HR Positive, LA/MBC (CONTESSA 2)

First Submitted : February 26, 2019
First Submitted that Met QC Criteria : February 28, 2019
First Posted : March 1, 2019

Last Update Submitted that Met QC Criteria : March 26, 2019
Last Update Posted : March 28, 2019